NET PROFIT (x1000 NOK)
EMPLOYEES
Frederiksstaden Pharma ApS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-81
|
-124
|
6 |
| Total assets |
646
|
495
|
374 |
| Current assets |
37
|
50
|
374 |
| Current liabilities |
491
|
271
|
47 |
| Equity capital |
156
|
225
|
327 |
| - share capital |
252
|
240
|
225 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
24.1%
|
45.5%
|
87.4% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
7.5%
|
18.5%
|
795.7% |
| Return on equity (ROE) |
-51.9%
|
-55.1%
|
1.8% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.